Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that diffuse alopecia of the scalp developed in some women during or after using oral contraceptive drugs, suggesting a potential link between the medication and hair loss.

This study found that the aromatic retinoic acid derivative Ro 10-9359 provided excellent results in 64% of severe psoriasis patients, especially in those with erythrodermic and pustular types, though relapses and side effects were noted.

In this study, nearly all predialysis chronic kidney disease patients had at least one dermatologic finding, with xerosis being the most common, highlighting the prevalence and diversity of skin issues in this population.

This abstract outlines the historical development and medical validation of artificial hair implants, particularly the approval and improvement of the Biofibre® implant technique in Europe and Australia, and highlights its advantages as the latest advancement in hair restoration treatments.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

This case report found that dermoscopy, showing characteristic "comma" and "corkscrew" hairs, effectively identified tinea capitis in a 7-year-old girl, allowing for early treatment before confirmation with fungal culture.

In this report, Biofibre® medical hair prosthetic fibers were shown to meet safety and biocompatibility standards, offering immediate aesthetic results for hair loss treatment with minor surgical intervention and reversible implantation, but requiring good after-care and yearly maintenance for optimal cosmetic outcomes.

This comment discusses the use of 'follicular Swiss cheese' as a diagnostic feature for alopecia areata and does not report new clinical findings.

This article discusses the various cosmetic, medical, and surgical treatment options for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of differential diagnosis in treatment planning.

This review discusses the role of ferritin in iron homeostasis and its potential utility in diagnosing iron deficiency as a cause of hair loss, while noting that ferritin's impact on skin and hair disorders is not fully understood.

This piece presents a case study of a woman with diffuse alopecia, suggesting a potential link to a chronic focus of infection rather than acute fever.

In this study, researchers observed diffuse hair loss in Japanese patients post-hematopoietic stem cell transplantation and chemotherapy, with treatments targeting hair follicle miniaturization, like topical minoxidil, improving hair volume in about 52.9% of cases.

This study observed that among 120 patients recovering from COVID-19, severe diffuse hair loss typically began less than two months post-infection, with the majority of patients experiencing a severe degree of hair loss and positive hair pull tests, often alongside vitamin D deficiency.

This review discusses the importance of physical examinations in trichology, emphasizing their role in diagnosing conditions like alopecia and hair dystrophies, and reports no new clinical results.

This paper reports a rare case where AL amyloidosis presented as isolated scalp alopecia, underscoring the importance of considering systemic amyloidosis in the differential diagnosis of alopecia.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

This study found that postmenopausal women experience two distinct patterns of hair changes, with diffuse scalp hair loss linked to body hair loss and age, and frontal hair loss associated with increased facial hair and a younger age.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

This abstract does not provide any research results; it outlines website navigation and access instructions for the JAMA network.

This article illustrates the impact of direct-to-consumer drug advertising through a case where a patient sought Rogaine for hair loss without medical assessment, revealing secondary syphilis-related symptoms instead.

This study reported that low-dose oral minoxidil combined with a 5α-reductase inhibitor improved hair density in most men with female pattern hair loss after 6 months or more of treatment.

This article discusses reported cases of diffuse scalp hair thinning in women using amphetamines and suggests no clear cause-effect relationship with amphetamine use based on available evidence.

This study reported that among patients aged 19 to 60 who experienced hair loss after COVID-19, a treatment involving a complex drug and peptide lotion led to hair improvement in 92% of cases, with good tolerability and no reported side effects.

This study reported that androgenetic alopecia in women becomes more prevalent with age, with risk factors including heredity and endocrine disorders, and differs clinically from male-pattern hair loss by causing diffuse hair thinning rather than loss at the temples or crown.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

This study found that most cases of telogen effluvium in Iraqi women had no clear triggering factor, although significant hair thinning was uncommon.

In this study, most Iraqi women with telogen effluvium had no identifiable triggers, though severe stress was noted in 21% of cases prior to the condition onset.

This article discusses primary cutaneous virilism, focusing on alopecia in women with androgen-dependent skin conditions, and reports no new findings.

This letter humorously reflects on aging and disputes the notion of "Geezer syndrome" linked to the Great Depression, emphasizing resilience and growth in knowledge over time.

This article reviews the social and functional impact of eyebrow loss and highlights the limited treatment options compared to scalp alopecia, but reports no new clinical results.